|
|
N/A
|
90K
$0
|
|
|
|
N/A
|
39.1K
$0
|
|
|
|
N/A
|
12.4K
$0
|
|
|
|
N/A
|
98K
$0
|
|
|
|
N/A
|
158K
$0
|
|
|
|
N/A
|
113K
$0
|
|
|
|
N/A
|
10.6K
$0
|
|
|
|
N/A
|
66.3K
$0
|
|
|
|
N/A
|
16.2K
$0
|
|
|
|
N/A
|
170K
$0
|
|
|
|
N/A
|
73.6K
$0
|
|
|
|
N/A
|
19.2K
$0
|
|
|
|
N/A
|
33.9K
$0
|
|
|
|
N/A
|
41K
$0
|
|
|
|
N/A
|
10.2K
$0
|
|
Avadel Pharmaceuticals PLC
|
|
N/A
|
92K
$0
|
|
Biomarin Pharmaceutical Inc
|
|
N/A
|
168K
$0
|
|
|
|
N/A
|
34.6K
$0
|
|
|
|
N/A
|
41.7K
$0
|
|
|
|
N/A
|
25.8K
$0
|
|
Checkpoint Therapeutics Inc
|
|
N/A
|
20.2K
$0
|
|
|
|
N/A
|
16.9K
$0
|
|
|
|
N/A
|
18.4K
$0
|
|
|
|
N/A
|
15.7K
$0
|
|
|
|
N/A
|
29.4K
$0
|
|
Federated Hermes ETF Trust
|
|
N/A
|
1.74M
$0
|
|
|
|
N/A
|
13.1K
$0
|
|
|
|
N/A
|
12K
$0
|
|
|
|
N/A
|
253K
$0
|
|
|
|
N/A
|
4.42K
$0
|
|
|
|
N/A
|
17.8K
$0
|
|
First Tr Exchng Traded Fd Vi
|
|
N/A
|
40.3K
$0
|
|
First Tr Exchng Traded Fd Vi
|
|
N/A
|
16K
$0
|
|
First Tr Exchng Traded Fd Vi
|
|
N/A
|
95.4K
$0
|
|
First Tr Exchng Traded Fd Vi
|
|
N/A
|
40.3K
$0
|
|
First Tr Exchng Traded Fd Vi
|
|
N/A
|
40K
$0
|
|
First Tr Exchng Traded Fd Vi
|
|
N/A
|
56.8K
$0
|
|
First Tr Exchng Traded Fd Vi
|
|
N/A
|
47K
$0
|
|
First Tr Exchng Traded Fd Vi
|
|
N/A
|
82.2K
$0
|
|
First Tr Exchng Traded Fd Vi
|
|
N/A
|
280K
$0
|
|
First Tr Exchng Traded Fd Vi
|
|
N/A
|
198K
$0
|
|
First Tr Exchng Traded Fd Vi
|
|
N/A
|
10K
$0
|
|
|
|
N/A
|
130K
$0
|
|
First Tr Exchng Traded Fd Vi
|
|
N/A
|
65.3K
$0
|
|
First Tr Exchng Traded Fd Vi
|
|
N/A
|
168K
$0
|
|
First Tr Exchng Traded Fd Vi
|
|
N/A
|
316K
$0
|
|
|
|
N/A
|
121K
$0
|
|
First Tr Exchng Traded Fd Vi
|
|
N/A
|
182K
$0
|
|
First Tr Exchng Traded Fd Vi
|
|
N/A
|
401K
$0
|
|
|
|
N/A
|
227K
$0
|
|